Showing results (371-380 of 385) with videos related to
Sort By:
Pageof 39
Transplantation|January 1, 1988
Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor-specific transfusion and living-related donor transplantation. A multicenter evaluationM R Weir, M L Henry, M Blackmore, et al.Annals of Surgery|January 1, 1980
Beneficial effects of aggressive protein feeding in severely burned childrenJ W Alexander, B G MacMillan, J D Stinnett, et al.Cancer|April 15, 1982
Canine osteogenic sarcoma treated by amputation and MER: an adverse effect of splenectomy on survivalJ A Meyer, R T Dueland, E G MacEwen, et al.Transplantation|February 1, 1992
The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trialJ W Alexander, G F Babcock, M R First, et al.Transplantation|January 1, 1989
Successful retreatment of allograft rejection with OKT3M R First, T J Schroeder, P E Hurtubise, et al.Image--The Journal of Nursing Scholarship|April 1, 1997
National Delphi study to determine competencies for nursing leadership in public healthT R Misener, J W Alexander, A J Blaha, et al.Transplantation Proceedings|April 26, 2005
Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantationC C Rogers, R R Alloway, R Boardman, et al.Transplantation Proceedings|April 26, 2005
Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimensE S Woodle, B Susskind, R R Alloway, et al.Journal of Clinical Laboratory Analysis|January 1, 1991
Selection criteria for liver transplant donorsT J Schroeder, A J Pesce, F C Ryckman, et al.Transplantation Proceedings|April 1, 1988
Cyclosporine pharmacokinetics in pancreas transplant recipientsR Munda, T J Schroeder, S A Pedersen, et al.Pageof 39